{"meta":{"query_hash":"1120bd5997d2","filters":{"venue":"OphthaTherapy Therapies in Ophthalmology"},"cohort_total":1,"direct_labels_cover":0,"predictions_cover":1,"exported":1,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/1120bd5997d2","api":"https://metacan.xera.ac/api/v1/cohort?venue=OphthaTherapy+Therapies+in+Ophthalmology"},"results":[{"id":"W3023597032","doi":"10.24292/01.ot.310320.05","title":"Potencjalne zastosowanie agonistów dopaminergicznych D2 w leczeniu VEGF-zależnych chorób oczu","year":2020,"lang":"pl","type":"article","venue":"OphthaTherapy Therapies in Ophthalmology","topic":"Neurological Complications and Syndromes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Tellabs (Canada)","funders":"","keywords":"Agonist; Medicine; Nuclear chemistry; Chemistry; Chromatography; Internal medicine; Receptor","score_opus":0.0700454987480153,"score_gpt":0.31805625460356374,"score_spread":0.24801075585554844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3023597032","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5843291,0.3451123,0.013045158,0.006798891,0.0014820594,0.0002886902,0.0023855837,0.0003342015,0.04622409],"genre_scores_gemma":[0.8758161,0.097942084,0.0053941817,0.0011814499,0.0003229978,0.00024390571,0.000831184,0.000068960595,0.01819905],"study_design_codex":"bench_or_experimental","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9994615,0.00010631572,0.00005693792,0.00015015042,0.00015532174,0.00006977078],"domain_scores_gemma":[0.999723,0.00007289846,0.00006770762,0.000029356359,0.000065909095,0.000041075953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003894338,0.00043108378,0.0005300326,0.0006349921,0.0005527781,0.0018373069,0.00045187798,0.0008278125,0.006050134],"category_scores_gemma":[0.00071228377,0.0003165489,0.0005549132,0.00048270682,0.0006982587,0.0009511119,0.0007705109,0.0012385643,0.0009517043],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039555393,0.0004521566,0.01367796,0.007810692,0.00069401716,0.0022777726,0.0015743235,0.000837933,0.661742,0.013224447,0.006517323,0.28723574],"study_design_scores_gemma":[0.00047893508,0.003748288,0.0981334,0.0014716196,0.0013684547,0.009795041,0.003550131,0.0021131353,0.5179519,0.014203308,0.34694418,0.0002416247],"about_ca_topic_score_codex":0.0029438008,"about_ca_topic_score_gemma":0.0040471666,"teacher_disagreement_score":0.006050134,"about_ca_system_score_codex":0.0010426213,"about_ca_system_score_gemma":0.0011033593,"threshold_uncertainty_score":0.02023971},"labels":[],"label_agreement":null}]}